Oncology
Table of Contents
Oncology is dedicated to the diagnosis, treatment, and prevention of cancer across all organ systems.
- Brain Cancer — primary brain tumors, GBM, WHO 2021 molecular classification, IDH mutation, MGMT methylation, Stupp protocol, 5-ALA surgery, TTFields
- Breast Cancer — HR+/HER2/triple-negative subtypes, BRCA testing, mammography, endocrine therapy
- Cancer — overview, staging systems, prevention, screening guidelines
- Cervical Cancer — HPV cause, vaccination, Pap and HPV screening, prevention
- Colorectal Cancer — adenoma-to-carcinoma sequence, colonoscopy vs FIT screening, early-onset rise
- Endometrial Cancer — uterine cancer, unopposed estrogen, postmenopausal bleeding, Lynch syndrome
- Esophageal Cancer — adenocarcinoma vs squamous, Barrett's esophagus, GERD pathway, dysphagia
- Head and Neck Cancer — oral cavity, oropharynx, larynx, hypopharynx, salivary glands; HPV-positive oropharyngeal SCC, RTOG 91-11 larynx preservation, pembrolizumab first-line R/M
- Kidney Cancer — renal cell carcinoma, incidental detection, VHL/HIF biology, immunotherapy
- Leukemia — ALL, AML, CLL, CML, chemotherapy, targeted therapy
- Liver Cancer — hepatocellular carcinoma, cirrhosis surveillance, hepatitis, fatty liver
- Lung Cancer — NSCLC and SCLC, low-dose CT screening, targeted therapy, immunotherapy
- Lymphoma — Hodgkin and non-Hodgkin, Ann Arbor staging, immunotherapy
- Mesothelioma — asbestos-related pleural cancer, 20-50 year latency, cisplatin + pemetrexed (EMPHACIS), nivolumab + ipilimumab (CheckMate 743), HIPEC for peritoneal
- Metastatic Cancers — spread patterns, systemic therapy, palliative care
- Nasopharyngeal Cancer — EBV-driven; endemic in Southern China and Southeast Asia; plasma EBV DNA biomarker; intensity-modulated radiotherapy + concurrent cisplatin; gemcitabine + cisplatin for recurrent/metastatic disease
- Multiple Myeloma — plasma cell neoplasm, CRAB criteria, proteasome inhibitors
- Ovarian Cancer — fallopian-tube origin, BRCA testing, CA-125, PARP inhibitors
- Pancreatic Cancer — PDAC, late presentation, Whipple surgery, FOLFIRINOX
- Penile Cancer — squamous cell carcinoma, HPV and phimosis pathways, sentinel lymph node biopsy, organ-sparing surgery, TIP chemotherapy
- Prostate Cancer — PSA screening, Gleason grading, active surveillance, hormone therapy
- Sarcoma — bone and soft tissue tumors, surgical management
- Skin Cancer — basal cell, squamous cell, melanoma, ABCDE rule, Mohs surgery
- Stomach Cancer — gastric cancer, H. pylori cause, Correa cascade, prevention
- Thyroid Cancer — papillary, follicular, medullary, anaplastic, BRAF mutations, RAI therapy
- Vulvar Cancer — vulvar squamous cell carcinoma, HPV and lichen sclerosus pathways, FIGO staging, sentinel lymph node biopsy (GROINSS-V), chemoradiation for locally advanced disease
Key Research Papers
Foundational and recent peer-reviewed publications across major oncology topics — immunotherapy, targeted therapy, screening, breast/prostate/lung/colon cancer, hematologic malignancies, and supportive care. Each citation links to the full text via DOI.
- Hodi FS, O'Day SJ, McDermott DF, et al. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma. New England Journal of Medicine. 2010;363(8):711-723. — doi:10.1056/NEJMoa1003466
- Reck M, Rodríguez-Abreu D, Robinson AG, et al. Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer (KEYNOTE-024). New England Journal of Medicine. 2016;375(19):1823-1833. — doi:10.1056/NEJMoa1606774
- Slamon DJ, Leyland-Jones B, Shak S, et al. Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2. New England Journal of Medicine. 2001;344(11):783-792. — doi:10.1056/NEJM200103153441101
- Topalian SL, Hodi FS, Brahmer JR, et al. Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer. New England Journal of Medicine. 2012;366(26):2443-2454. — doi:10.1056/NEJMoa1200690
- Druker BJ, Talpaz M, Resta DJ, et al. Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia. New England Journal of Medicine. 2001;344(14):1031-1037. — doi:10.1056/NEJM200104053441401
- National Lung Screening Trial Research Team. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening. New England Journal of Medicine. 2011;365(5):395-409. — doi:10.1056/NEJMoa1102873
- Ferlay J, Colombet M, Soerjomataram I, et al. Cancer Statistics for the Year 2020: An Overview. International Journal of Cancer. 2021;149(4):778-789. — doi:10.1002/ijc.33588
- Cardoso F, Kyriakides S, Ohno S, et al. Early Breast Cancer: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up. Annals of Oncology. 2019;30(8):1194-1220. — doi:10.1093/annonc/mdz173
- Hanahan D, Weinberg RA. Hallmarks of Cancer: The Next Generation. Cell. 2011;144(5):646-674. — doi:10.1016/j.cell.2011.02.013
- June CH, Sadelain M. Chimeric Antigen Receptor Therapy. New England Journal of Medicine. 2018;379(1):64-73. — doi:10.1056/NEJMra1706169
- Larkin J, Chiarion-Sileni V, Gonzalez R, et al. Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma (CheckMate 067). New England Journal of Medicine. 2015;373(1):23-34. — doi:10.1056/NEJMoa1504030
- Bretthauer M, Løberg M, Wieszczy P, et al. Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death (NORDICC Trial). New England Journal of Medicine. 2022;387(17):1547-1556. — doi:10.1056/NEJMoa2208375
- André T, Shiu KK, Kim TW, et al. Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer (KEYNOTE-177). New England Journal of Medicine. 2020;383(23):2207-2218. — doi:10.1056/NEJMoa2017699
- Maude SL, Laetsch TW, Buechner J, et al. Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia (ELIANA). New England Journal of Medicine. 2018;378(5):439-448. — doi:10.1056/NEJMoa1709866
- DiNardo CD, Jonas BA, Pullarkat V, et al. Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia (VIALE-A). New England Journal of Medicine. 2020;383(7):617-629. — doi:10.1056/NEJMoa2012971
- Temel JS, Greer JA, Muzikansky A, et al. Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer. New England Journal of Medicine. 2010;363(8):733-742. — doi:10.1056/NEJMoa1000678
PubMed Topic Searches
The following PubMed topic searches surface current peer-reviewed literature across oncology subfields. Each link opens a live query; results update as new papers are indexed.
- PubMed: Oncology review
- PubMed: Cancer epidemiology
- PubMed: Cancer staging
- PubMed: Chemotherapy
- PubMed: Immunotherapy & checkpoint inhibitors
- PubMed: Targeted therapy
- PubMed: Precision oncology & tumor genomics
- PubMed: Cancer screening guidelines
- PubMed: Cancer biomarkers
- PubMed: Radiation therapy
- PubMed: Cancer survivorship
- PubMed: Palliative care
Herbs Traditionally Used for Cancer
The coloured half of every capsule shows how much human evidence supports that herb for this condition. None of these replace a diagnosis, and the marked cautions are there because the harm is documented.
Connections
- All Conditions
- How Cancer Spreads (Metastasis) — interactive animation
- Stem Cells: The Body's Blank Slates — interactive animation
- How Genes Are Switched On and Off — interactive animation
- Mitosis: How One Cell Becomes Two — interactive animation
- Telomeres: Why Cells Grow Old — interactive animation
- How Your DNA Is Repaired — and Why It Fails in Cancer — interactive animation
- The Cell Cycle & How Cancer Hijacks It — interactive animation
- The Lymphatic System: Your Body’s Drainage & Surveillance — interactive animation
- Cancer
- Brain Cancer
- Mesothelioma
- Leukemia
- Lymphoma
- Multiple Myeloma
- Sarcoma
- Thyroid Cancer
- Vulvar Cancer
- Penile Cancer
- Metastatic Cancers
- Selenium and Cancer Prevention — selenoprotein biology, the NPC and SELECT trials, evidence across prostate/colorectal/lung cancers, and the U-shaped dose-response curve.
- Turmeric
- Vitamin D3
- Otto Warburg — cancer metabolism, the Warburg effect, and the PET scan's Nobel roots
- Harald zur Hausen — the HPV Nobel, and the vaccine that prevents cervical cancer
- Allison & Honjo — checkpoint immunotherapy and where it does and does not work
- Bishop & Varmus (Nobel 1989) — the cellular origin of oncogenes, why targeted therapy needs its target, and why cancer risk climbs so steeply with age
- Herbs covered on this site that discuss conditions in this specialty: Elephant's Foot (Elephantopus scaber) · Noni (Morinda citrifolia) · Shampoo Ginger (Zingiber zerumbet) · Black Turmeric (Curcuma caesia) · Crepe Ginger (Cheilocostus speciosus) · White Turmeric / Zedoary (Curcuma zedoaria)
All Oncology Articles A–Z
Every article in this specialty, listed alphabetically.
- Adrenocortical Carcinoma
- Anal Cancer
- Bladder Cancer
- Brain Cancer
- Breast Cancer
- Cancer
- Cervical Cancer
- Cholangiocarcinoma
- Colorectal Cancer
- Endometrial Cancer
- Esophageal Cancer
- Ewing Sarcoma
- Gallbladder Cancer
- Gastrointestinal Stromal Tumor (GIST)
- Giant Cell Tumor of Bone
- Head and Neck Cancer
- Hepatocellular Carcinoma
- Kidney Cancer
- Leukemia
- Liver Cancer
- Lung Cancer
- Lymphoma
- Merkel Cell Carcinoma
- Mesothelioma
- Metastatic Cancers
- Multiple Myeloma
- Nasopharyngeal Cancer
- Neuroblastoma
- Neuroendocrine Tumors (NETs)
- Oral Cancer
- Osteosarcoma
- Ovarian Cancer
- Pancreatic Cancer
- Penile Cancer
- Pheochromocytoma and Paraganglioma (PPGL)
- POEMS Syndrome
- Primary CNS Lymphoma (PCNSL)
- Prostate Cancer
- Renal Cell Carcinoma (RCC)
- Retinoblastoma
- Sarcoma
- Skin Cancer
- Soft Tissue Sarcoma
- Stomach Cancer
- Testicular Cancer
- Thymoma
- Thyroid Cancer
- Uveal Melanoma
- Vulvar Cancer
- Wilms Tumor
Featured Videos